trianrix
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
1
Earliest trial started May 1, 2011 (NCT01357720)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 3 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Tetanus toxinImmunity, active
tetX immunity, active
- Bordetella pertussisImmunity, active
Bordetella pertussis immunity, active
- Diphtheria toxinImmunity, active
Diphtheria toxin immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- trianrix
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02207816 | Phase 3 | Sep 18, 2014 | GlaxoSmithKline |
| NCT01357720 | Phase 4 | May 1, 2011 | Crucell |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Crucell | For profit | 1 | 1 | 1 | 2011 |
| GlaxoSmithKline | For profit | 1 | 1 | 1 | 2014 |
2 organizations
Page 1 / 1